Real-World Efficacy And Safety Of Peptide Receptor Radionuclide Therapy (Prrt) In Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets).

JOURNAL OF CLINICAL ONCOLOGY(2021)

Cited 0|Views10
No score
Abstract
364Background: PRRT with 177Lu-Dotatate (Lutathera) is a radiolabeled somatostatin analog indicated treatment of somatostatin receptor (STTR) positive GEP-NETs. The study aims to establish the effi...
More
Translated text
Key words
peptide receptor radionuclide therapy,gastroenteropancreatic neuroendocrine tumors,neuroendocrine tumors,real-world,gep-nets
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined